Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 36Leukemia 33Anemia, Refractory, with Excess of Blasts 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Leukemia, Myeloid, Chronic-Phase 25Leukemia, Myeloid, Acute 24Lymphoma 22Leukemia, Myeloid, Accelerated Phase 22Leukemia, Lymphocytic, Chronic, B-Cell 20Myeloproliferative Disorders 18Burkitt Lymphoma 18Lymphoma, Non-Hodgkin 17Lymphoma, Follicular 17Leukemia, Myelomonocytic, Chronic 17Multiple Myeloma 16Lymphoma, Mantle-Cell 16Lymphoma, B-Cell, Marginal Zone 16Hodgkin Disease 16Anemia, Refractory 16Myelodysplastic-Myeloproliferative Diseases 15Lymphoma, Large-Cell, Immunoblastic 15Lymphoma, Large B-Cell, Diffuse 15Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 15Dendritic Cell Sarcoma, Interdigitating 15Congenital Abnormalities 15Recurrence 13Neoplasms, Plasma Cell 13Blast Crisis 13Primary Myelofibrosis 12Waldenstrom Macroglobulinemia 8

Interventions

Thiotepa 3Melphalan 3Cyclophosphamide 3fludarabine phosphate 2fludarabine 2Busulfan 2Alemtuzumab 2Whole-Body Irradiation 1Tacrolimus 1Muromonab-CD3 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Immunotherapy 1Drug Therapy 1Antilymphocyte Serum 1Antibodies 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Histiocytosis × Antilymphocyte Serum × Classical hematology × Clear all
NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡